Literature DB >> 1576278

Sepsis due to Rhodotorula related to use of indwelling central venous catheters.

T E Kiehn1, E Gorey, A E Brown, F F Edwards, D Armstrong.   

Abstract

With increased use of surgically implanted silastic central venous catheters, there has been an increase in the recovery from blood cultures at Memorial Sloan-Kettering Cancer Center (New York) of environmental and skin organisms including the red yeast Rhodotorula. From 1985 through 1989, 23 patients had catheter-related Rhodotorula sepsis. All 23 patients had indwelling central venous catheters that had been in place from 1 to 22 months (average, 9.3 months) prior to the detection of fungemia. All patients had blood drawn both through the catheter and from a peripheral source, and only one patient had a peripheral blood culture positive for Rhodotorula. Colony counts of yeast from the catheter cultures often exceeded 100 (15 patients) and even 1,000 (seven patients) cfu/mL of blood. Thirteen of the patients were treated with antifungal therapy and had the catheter removed, and five patients received antifungal therapy without catheter removal (suggesting that compulsory removal of the catheter may not always be required). Five patients had the catheter removed without antifungal therapy. All patients survived the fungemic episode and experienced no recurrence of the infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576278     DOI: 10.1093/clinids/14.4.841

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Rhodotorula rubra endophthalmitis in an HIV positive patient.

Authors:  A B Merkur; W G Hodge
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  Activities of available and investigational antifungal agents against rhodotorula species.

Authors:  D J Diekema; B Petroelje; S A Messer; R J Hollis; M A Pfaller
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

Authors:  Maria N Chitasombat; Diamantis P Kofteridis; Ying Jiang; Jeffrey Tarrand; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2011-11-11       Impact factor: 6.072

Review 4.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Catheter-related sepsis due to Rhodotorula glutinis.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Shen-Wu Ho; Kwen-Tay Luh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Authors:  Aimee K Zaas; Molly Boyce; Wiley Schell; Barbara Alexander Lodge; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

7.  Occurrence of yeasts in cloacae of migratory birds.

Authors:  C Cafarchia; A Camarda; D Romito; M Campolo; N C Quaglia; D Tullio; D Otranto
Journal:  Mycopathologia       Date:  2006-04       Impact factor: 2.574

8.  Antifungal activity of four honeys of different types from Algeria against pathogenic yeast: Candida albicans and Rhodotorula sp.

Authors:  Ahmed Moussa; Djebli Noureddine; Aissat Saad; Meslem Abdelmelek; Benhalima Abdelkader
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

9.  Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables.

Authors:  R Perniola; M L Faneschi; E Manso; M Pizzolante; A Rizzo; A Sticchi Damiani; R Longo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

Review 10.  Rhodotorula fungemia of an intensive care unit patient and review of published cases.

Authors:  Anastasia Spiliopoulou; Evangelos D Anastassiou; Myrto Christofidou
Journal:  Mycopathologia       Date:  2012-05-11       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.